We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.15B
AUM Growth
+$171M
Cap. Flow
-$50.7M
Cap. Flow %
-1.61%
Top 10 Hldgs %
39.38%
Holding
234
New
3
Increased
16
Reduced
102
Closed
4

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.5M
2
APO icon
Apollo Global Management
APO
+$21.5M
3
BB icon
BlackBerry
BB
+$7.83M
4
LUMN icon
Lumen
LUMN
+$5.06M
5
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$1.86M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$20.2M
2
JEF icon
Jefferies Financial Group
JEF
+$15.3M
3
BAX icon
Baxter International
BAX
+$13.3M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$12.6M
5
ABT icon
Abbott
ABT
+$6.71M

Sector Composition

Rank Sector Weight
1 Financials 29.01%
2 Healthcare 16.47%
3 Technology 12.09%
4 Communication Services 10.94%
5 Energy 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD icon
126
DuPont de Nemours
DD
$18.6B
$909K 0.03%
5,582
-302
-5% -$52K
BSX icon
127
Boston Scientific
BSX
$68.4B
$905K 0.03%
23,500
– –
EMR icon
128
Emerson Electric
EMR
$81.6B
$901K 0.03%
11,770
-10,275
-47% -$758K
EW icon
129
Edwards Lifesciences
EW
$49.4B
$877K 0.03%
15,120
– –
PEG icon
130
Public Service Enterprise Group
PEG
$38.7B
$866K 0.03%
16,400
– –
CSL icon
131
Carlisle Companies
CSL
$13.5B
$816K 0.03%
6,700
– –
UNH icon
132
UnitedHealth
UNH
$382B
$798K 0.03%
2,998
-225
-7% -$58.5K
GLW icon
133
Corning
GLW
$107B
$773K 0.02%
21,905
– –
CHCO icon
134
City Holding Co
CHCO
$2.05B
$757K 0.02%
9,860
-1
-0% -$79
NVS icon
135
Novartis
NVS
$302B
$737K 0.02%
9,542
– –
MCD icon
136
McDonald's
MCD
$193B
$735K 0.02%
4,395
-394
-8% -$63.1K
FLS icon
137
Flowserve
FLS
$8.94B
$731K 0.02%
13,362
– –
HES
138
DELISTED
Hess
HES
$716K 0.02%
10,000
– –
FTV icon
139
Fortive
FTV
$18.2B
$665K 0.02%
12,528
– –
ADP icon
140
Automatic Data Processing
ADP
$109B
$656K 0.02%
4,351
– –
WBA
141
DELISTED
Walgreens Boots Alliance
WBA
$655K 0.02%
8,988
-500
-5% -$34K
CELG
142
DELISTED
Celgene Corp
CELG
$648K 0.02%
7,237
– –
TSCO icon
143
Tractor Supply
TSCO
$16.3B
$633K 0.02%
34,855
-505
-1% -$8.4K
UN
144
DELISTED
Unilever NV New York Registry Shares
UN
$625K 0.02%
11,250
– –
TMM
145
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$543K 0.02%
327,000
-28,100
-8% -$46.7K
SO icon
146
Southern Company
SO
$108B
$532K 0.02%
12,200
– –
LMT icon
147
Lockheed Martin
LMT
$131B
$530K 0.02%
1,533
– –
IRM icon
148
Iron Mountain
IRM
$35.9B
$512K 0.02%
14,843
– –
TMO icon
149
Thermo Fisher Scientific
TMO
$214B
$494K 0.02%
2,025
– –
LBRDK icon
150
Liberty Broadband Class C
LBRDK
$4.89B
$486K 0.02%
5,761
– –
4 5
6
7 8

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q3 2018 Portfolio in Review

As of Q3 2018, Beck Mack & Oliver held 234 positions worth $3.15B, up 5.7% from $2.98B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3%. Beck Mack & Oliver opened 3 new positions and exited 4, leaving the 234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2018 buy was Teva Pharmaceuticals: 2,993,705 shares worth $64.5M.
  • Beck Mack & Oliver added most to Apollo Global Management in Q3 2018, an estimated $21.5M increase.
  • Beck Mack & Oliver's biggest Q3 2018 reduction was Merck, cutting an estimated $20.2M.
  • Beck Mack & Oliver fully exited JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non in Q3 2018, selling an estimated $211K.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $3.15B portfolio in Q3 2018.
  • Beck Mack & Oliver opened 3 new positions and closed 4 in Q3 2018.
  • Beck Mack & Oliver's portfolio value rose 5.7% quarter-over-quarter to $3.15B.

Based on Beck Mack & Oliver's 13F filing for Q3 2018, filed 29 Oct 2018.